Siga submits NDA for smallpox candidate

Siga Technologies Inc. (Pink:SIGA) submitted an NDA to FDA for oral TPOXX tecovirimat (oral ST-246) to treat smallpox infection. The company is seeking Priority Review of the small molecule antiviral...